Creative Biolabs has significantly expanded its in vitro diagnostic (IVD) capabilities through the integration of protein and nucleic acid detection services, marking a substantial advancement in molecular diagnostics and precision medicine. The company now offers systematic protein-level detection services that enable researchers to obtain reliable data even from limited sample volumes, leveraging proteins as direct mediators of physiological and pathological processes.
According to a Creative Biolabs expert, protein level studies track disease onset and development more rapidly than genetic testing alone. The company's high-sensitivity technology platforms ensure stable and reproducible results, which is crucial for disease diagnostics and drug development. The expanded services include comprehensive protein biomarker detection services utilizing ELISA, multiplex assays, mass spectrometry, and protein arrays for quantitative target detection and large-scale proteomics.
Creative Biolabs has also developed innovative combined nucleic acid and protein detection services that analyze both protein and nucleic acid signals simultaneously in a single assay. This integrated approach conserves sample volume and time while revealing cross-level molecular interactions, enhancing the rationale for early disease detection and clinical assessment. The combined detection method has demonstrated advantages in studies on complex conditions such as pancreatic cancer and cardiovascular disease.
The expansion of these services addresses the growing prominence of protein- and nucleic acid-based biomarkers, particularly for early disease detection. By rigorously controlling every step from sample preparation to data interpretation, Creative Biolabs ensures the delivery of reliable, high-quality data that meets the stringent standards of researchers. This advancement in IVD capabilities supports more accurate identification of disease patterns and could shape the future of diagnostic technologies, benefiting research in cancer, neurodegenerative diseases, and infectious diseases worldwide.
